Formation of indomethacin-saccharin cocrystals using supercritical fluid technology

被引:166
作者
Padrela, Luis [2 ]
Rodrigues, Miguel A. [2 ]
Velaga, Sitaram R. [1 ]
Matos, Henrique A. [2 ]
de Azevedo, Edmundo Gomes [2 ]
机构
[1] Lulea Univ Technol, Dept Hlth Sci, S-97187 Lulea, Sweden
[2] Inst Super Tecn, Dept Biol & Chem Engn, P-1049001 Lisbon, Portugal
基金
瑞典研究理事会;
关键词
Crystal engineering; Supercritical fluids; Indomethacin; Saccharin; Pharmaceutical cocrystals; Solid form screening; ASSISTED ATOMIZATION; NANOPARTICLES; MICROPARTICLES;
D O I
10.1016/j.ejps.2009.05.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The main objective of the present work is to check the feasibility of supercritical fluid (SCF) technologies in the screening and design of cocrystals (novel crystalline solids). The cocrystal formation tendencies in three different SCF techniques, focusing on distinct supercritical fluid properties - solvent, anti-solvent and atomization enhancer - were investigated. The effect of processing parameters on the cocrystal formation behaviour and particle properties in these techniques was also studied. A recently reported indomethacin-saccharin (IND-SAC) cocrystalline system was our model system. A 1:1 molar ratio of indomethacin (gamma-form) and saccharin was used as a starting material. The SCF techniques employed in the study include the CSS technique (cocrystallization with supercritical solvent), the SAS technique (supercritical anti-solvent),and the AAS technique (atomization and anti-solvent). The resulting cocrystalline phase was identified using differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and Fourier transform-Raman (FT-Raman). The particle morphologies and size distributions were determined using scanning electron microscopy (SEM) and aerosizer, respectively. The pure IND-SAC cocrystals were obtained from SAS and AAS processes, whilst partial to no cocrystal formation occurred in the CSS process. However, no remarkable differences were observed in terms of cocrystal formation at different processing conditions in SAS and AAS processes. Particles from CSS processes were agglomerated and large, whilst need le-to-block-shaped and spherical particles were obtained from SAS and AAS processes, respectively. The particle size distribution of these particles was 0.2-5 mu m. Particulate IND-SAC cocrystals with different morphologies and sizes (nano-to-micron) were produced using supercritical fluid techniques. This work demonstrates the potential of SCF technologies as screening methods for cocrystals with possibilities for particle engineering. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:9 / 17
页数:9
相关论文
共 25 条
[1]   Building co-crystals with molecular sense and supramolecular sensibility [J].
Aakeröy, CB ;
Salmon, DJ .
CRYSTENGCOMM, 2005, 7 :439-448
[2]   Crystal engineering of the composition of pharmaceutical phases.: Do pharmaceutical co-crystals represent a new path to improved medicines? [J].
Almarsson, Ö ;
Zaworotko, MJ .
CHEMICAL COMMUNICATIONS, 2004, (17) :1889-1896
[3]   Indomethacin-saccharin cocrystal:: Design, synthesis and preliminary pharmaceutical characterization [J].
Basavoju, Srinivas ;
Bostrom, Dan ;
Velaga, Sitaram P. .
PHARMACEUTICAL RESEARCH, 2008, 25 (03) :530-541
[4]   Supercritical fluid processing: a new route for materials synthesis [J].
Cansell, F ;
Chevalier, B ;
Demourgues, A ;
Etourneau, J ;
Even, C ;
Garrabos, Y ;
Pessey, V ;
Petit, S ;
Tressaud, A ;
Weill, F .
JOURNAL OF MATERIALS CHEMISTRY, 1999, 9 (01) :67-75
[5]  
Czerwonatis N, 2001, CHEM ENG TECHNOL, V24, P619, DOI 10.1002/1521-4125(200106)24:6<619::AID-CEAT619>3.0.CO
[6]  
2-H
[7]  
Desiraju GR., 1989, MAT SCI MONOGR, V54, pXIV
[8]  
Dipalma JR., 1976, Basic Pharmacology in Medicine
[9]   Particle generation for pharmaceutical applications using supercritical fluid technology [J].
Fages, J ;
Lochard, H ;
Letourneau, JJ ;
Sauceau, M ;
Rodier, E .
POWDER TECHNOLOGY, 2004, 141 (03) :219-226
[10]  
FOERSTER T, 2000, Patent No. 2000021490